Fenofibrate Treatment Enhances Antioxidant Status and Attenuates Endothelial Dysfunction in Streptozotocin-Induced Diabetic Rats

Table 1

Metabolic parameters for control (C) and diabetic (D) rats treated with/without fenofibrate (FF).

	Body Weight (g)	Blood glucose (mg/dl)	Total cholesterol (mg/dl)	Triglyceride (mg/dl)
C	243.5 ± 7.0	122.7 ± 6.7	50.5 ± 2.2	65.9 ± 4.3
D	183.8 ± 5.9*	359.2 ± 24.9*	64.4 ± 4.7*	119.8 ± 9.9*
C + FF	250.5 ± 5.2	117.7 ± 5.4	63.7 ± 4.0	90.0 ± 9.2
D + FF	182.6 ± 9.6*	378.5 ± 42.6*	68.2 ± 4.3*	81.7 ± 11.5

Data are expressed as mean ± SEM, 𝑛=10, *𝑃<.05 versus C.